feed,title,long_url,short_url
Benzinga,"Bluebird's Gene Therapy Scores US Approval For Genetic Blood Disorder, Probably The Most Expensive",https://benzinga.com/general/biotech/22/08/28540017/bluebirds-gene-therapy-scores-us-approval-for-genetic-blood-disorder-probably-the-most-expensive,https://bit.ly/3Pu6mnV
